[go: up one dir, main page]

JPH01283228A - Biodegradable sustained release material - Google Patents

Biodegradable sustained release material

Info

Publication number
JPH01283228A
JPH01283228A JP11019988A JP11019988A JPH01283228A JP H01283228 A JPH01283228 A JP H01283228A JP 11019988 A JP11019988 A JP 11019988A JP 11019988 A JP11019988 A JP 11019988A JP H01283228 A JPH01283228 A JP H01283228A
Authority
JP
Japan
Prior art keywords
amino acid
acid
sustained release
aspartic acid
decomposition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP11019988A
Other languages
Japanese (ja)
Inventor
Makoto Iwatsuki
誠 岩月
Toshiro Hayashi
林 寿郎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Priority to JP11019988A priority Critical patent/JPH01283228A/en
Publication of JPH01283228A publication Critical patent/JPH01283228A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

PURPOSE:To obtain the title material containing an amino acid polymer containing aspartic acid as a constituent amino acid and capable of arbitrarily controlling a rate of decomposition by a biological enzyme. CONSTITUTION:A biodegradable sustained release material containing a water soluble amino acid polymer containing aspartic acid as a constituent amino acid and having preferably 1,000-1000,000, especially 3,000-300,000 molecular weight. The decomposition rate can be arbitrarily controlled (since increase of aspartic acid content retards the decomposition) by changing the composition of aspartic acid acid in a constituent amino acid for the above-mentioned polymer. In the above-mentioned polymer, uses as a carrier for sustained release of medical enzyme preparation, modifier for preventing side effects and antigen, artificial skin, raw material for wound covering agent and carrier for cell culture are expected.

Description

【発明の詳細な説明】 (産業上の利用分野) 本発BAは新規生体分解徐放性材料に関し、例えば医薬
酵素製剤徐放用組体、医薬の副作用や抗原防止用修飾材
9人工皮膚や創傷被覆剤用素材、細胞培養担体を提供す
ることが期待される。
Detailed Description of the Invention (Field of Industrial Application) The present BA relates to novel biodegradable sustained release materials, such as assemblies for sustained release of pharmaceutical enzyme preparations, modified materials for preventing side effects of medicines and antigens, artificial skin, etc. It is expected to provide materials for wound dressings and cell culture carriers.

(従来の技術) アミノ酸は生体の構成要素であるタンノ々り質の構成成
分であり、生体に対して嫂和性が強く、安全性が高い物
質である。そのためこれをポリマー化して生体材料とし
て利用することが進められている。
(Prior Art) Amino acids are constituents of tannins, which are the constituents of living organisms, and are substances that are highly compatible with living organisms and are highly safe. Therefore, progress is being made to make it into a polymer and use it as a biomaterial.

アミノ酸の中にあって、グルタミン酸は、■安価でおり
、■ポリマー化が容易で、高分子量化も容易である。ま
た、得られたポリグルタミン酸は■水溶性である、■水
溶液の一値を変化させることKより、ポリマーの構造(
α−ヘリックス構造からβ−ジグザク構造ランダム・コ
イル構造へ)が可逆的に変化する。■側鎖のγ位カルが
キシル基に化学的に各種の活性物質を担持てきる等、の
利点かあ)、(文献G、F、Rowland、 5ta
l、 Naturs+(London)、 255,4
87(1975))賞月されている。
Among amino acids, glutamic acid is 1) inexpensive, 2) easily polymerized, and easily made to have a high molecular weight. In addition, the obtained polyglutamic acid is 1) water-soluble; 2) the polymer structure (
(from α-helical structure to β-zigzag random coil structure) changes reversibly. ■Advantages such as the ability of the γ-position of the side chain to chemically support various active substances on the xyl group), (References G, F, Rowland, 5ta)
l, Naturs+ (London), 255,4
87 (1975)) Awarded the award.

グルタミン酸を含む水溶性ポリアミノ酸は、酵素による
分解が極めて速く、(比較的遅い分解性が要求されるよ
うな医用)用途と目的に応じた分解徐放性を持たせるこ
とが困難である。ポリグルタミン酸の酵素による分解を
遅くする方法としては、側鎖のγ位のカルボキシル基を
エステル化やアミド化する方法がある。しかしながら、
それによシ水溶性が失われたり、本来の機能が減殺され
るため生体分解徐放性の水溶性ポリアミノ酸として適さ
なくなる(文献T、Hayashl atal、 So
n−IGakkml−ski、 44.59(1988
) )。
Water-soluble polyamino acids containing glutamic acid are decomposed extremely rapidly by enzymes, and it is difficult to provide them with sustained decomposition and release properties that suit the purpose and application (such as medical applications that require relatively slow degradability). As a method of slowing down the enzymatic decomposition of polyglutamic acid, there is a method of esterifying or amidating the carboxyl group at the γ-position of the side chain. however,
As a result, water solubility is lost or the original function is diminished, making it unsuitable as a biodegradable sustained release water-soluble polyamino acid (Reference T, Hayashl atal, So
n-IGakkml-ski, 44.59 (1988
) ).

(発明が解決しようとする課題) 生体材料として生体内を酵素による分解速度を任意に制
御できる実用性のある水溶性アミノ酸ポリマーの開発が
望まれている。
(Problems to be Solved by the Invention) It is desired to develop a practical water-soluble amino acid polymer that can be used as a biomaterial and whose decomposition rate by enzymes can be arbitrarily controlled in the living body.

(課題を解決するための手段) 本発明者らは、前記課題を解決すべく鋭意検討し九結果
構成アミノ酸としてアスパラギン酸を含むポリアミノ酸
が生体中酵素の基質特異性によシ分解速度が遅くなるこ
と、更に構成アミノ酸中のアスパラギン酸の組成を変え
ることにより水溶性ポリアミノ酸の分解速度を任意に制
御できることを見出し、この発見に基いて本発明を完成
するに到りた。
(Means for Solving the Problems) The present inventors have made extensive studies to solve the above problems, and have found that polyamino acids containing aspartic acid as constituent amino acids have a slow decomposition rate due to the substrate specificity of enzymes in living organisms. Furthermore, the inventors have discovered that the decomposition rate of water-soluble polyamino acids can be arbitrarily controlled by changing the composition of aspartic acid among the constituent amino acids, and have completed the present invention based on this discovery.

本発明に使用するポリアミノ酸は水溶性であり、構成ア
ミノ酸としてアスパラギン酸を含むものであればよい。
The polyamino acid used in the present invention may be any one as long as it is water-soluble and contains aspartic acid as a constituent amino acid.

分子量は特に制限はないが、分解速Vおよび生体内での
安定性の点で3.000〜i o、o、ooo。
The molecular weight is not particularly limited, but is 3.000 to io, o, ooo in terms of decomposition rate V and in vivo stability.

程度がよい。構成アミノ酸は、天然に存するという点で
L一体が好ましい。
Good condition. The constituent amino acids are preferably L-units because they occur naturally.

構成アミノ酸としては他にグルタミン酸等の酸性アミノ
酸、アラニン等の中性アミノ酸、リジン、アルギニン等
の塩基性アミノ酸、メチオニン、システィン等の合価ア
ミノ酸、フェニルアラニン等の芳香族アミノ酸、ゾロリ
ン等の環状アミノ酸を採用することができる。ポリアミ
ノ酸は、天然由来ではない側鎖を有していてもより0本
発明に使用するポリアミノ酸は、その主鎖にエーテル、
エステル、ウレタン結合等を有する成分を!ロック共重
合等により有するものも含まれる。
Constituent amino acids include acidic amino acids such as glutamic acid, neutral amino acids such as alanine, basic amino acids such as lysine and arginine, synthetic amino acids such as methionine and cysteine, aromatic amino acids such as phenylalanine, and cyclic amino acids such as zoroline. Can be adopted. The polyamino acid used in the present invention has an ether or an ether in its main chain.
Ingredients with ester, urethane bonds, etc.! It also includes those obtained by lock copolymerization or the like.

ポリアミノ酸を本発明の徐放性材料として使用する場合
、例えば、粉末状、水溶液、あるーは水溶液をジアミン
などの適当な架橋剤で処理することにより得られるハイ
ドログル状で使用することができるが、状態、形状は使
用目的により任意に選択することができる。
When polyamino acids are used as the sustained release material of the present invention, they can be used, for example, in the form of powder, aqueous solution, or hydrogel obtained by treating the aqueous solution with a suitable crosslinking agent such as diamine. However, the state and shape can be arbitrarily selected depending on the purpose of use.

(実施例) 以下、実施例により本発明の詳細な説明する。(Example) Hereinafter, the present invention will be explained in detail with reference to Examples.

実施例14!リアミノ酸の製造 ■ポリーL−アスノぐラギン酸の調製 L−7スノクラギン酸−β−ベンジルエステル再結晶し
たMA−NCA 5 #をトリエチルアミンぐノ (IAO当t)を重合開始剤として、溶媒としジオキサ
ンとアセトニトリルの1対1混合溶液50mを使用し室
温で重合反応を行ないポリ−β−ベンジル−L−アスパ
ルテート(以下、「pnLAJ と略す。)4Iを得た
Example 14! Preparation of poly-L-asnocragic acid Preparation of L-7 sunocragic acid β-benzyl ester Recrystallized MA-NCA 5 # was mixed with triethylamine (IAO equivalent) as a polymerization initiator and dioxane as a solvent. Poly-β-benzyl-L-aspartate (hereinafter abbreviated as "pnLAJ") 4I was obtained by carrying out a polymerization reaction at room temperature using 50 ml of a 1:1 mixed solution of 1:1 and acetonitrile.

トリフロルメタンスルホン酸法(トリフ0ルメタンスル
ホン酸1.31dチオアニソール1.gmJ、m−クレ
ゾール0.2N及びトリフロロ酢酸121111の混合
溶液で処理する方法)により、前記得られ九PBLAを
0℃下で3時間処理し脱ベンジル化を行ないポリーL−
アスノ母うギン!!(以下、「PLAA」と略す。)を
1.99得た。分子量:16,600(超遠心法に、I
sける沈降平衡法 から求めた重量平均分子量@ポリー
L−グルタミン酸の調製 L−グルタミン酸−γ−ベンジルエステル20Iを出発
原料として前記■と同様の方法によりボIJ−L−グル
タミンM2.1Nを得た。重量平均分子ji:48,8
00 θコボlJ、−L−アスノぐラギンl#/−L−グルタ
ミン酸の製造 L−アスパラギン酸−β−ベンジルエステルNCA 2
. Oliとし、BA−NCAとグルタミン酸−γ−ベ
ンジルエステルNCA O,、6〜2.4 N トヲf
fi定)%ル比で配合し前記■と同様の方法によシ重合
反応を行々い、上記目的のコポリマーを製造した。
By the trifluoromethanesulfonic acid method (method of treating with a mixed solution of 1.31 d of trifluoromethanesulfonic acid and 1.gmJ of thioanisole, 0.2N of m-cresol, and 121111 of trifluoroacetic acid), the nine PBLA obtained above was heated to 0°C. Poly L-
Asuno's mother Ugin! ! (hereinafter abbreviated as "PLAA") was obtained at 1.99. Molecular weight: 16,600 (for ultracentrifugation, I
Preparation of poly L-glutamic acid with a weight average molecular weight determined from the sedimentation equilibrium method using L-glutamic acid-γ-benzyl ester 20I as a starting material. BoIJ-L-glutamine M2.1N was obtained in the same manner as in the above ①. . Weight average molecule ji: 48,8
00 θCobo lJ, -L-asnoglagine l#/-Production of L-glutamic acid L-aspartic acid-β-benzyl ester NCA 2
.. Oli, BA-NCA and glutamic acid-γ-benzyl ester NCA O,, 6-2.4 N tof
A polymerization reaction was carried out in the same manner as in (1) above to produce the desired copolymer.

CC−AC−50>はモル比1/1で、2.OJを得た
CC-AC-50> has a molar ratio of 1/1, and 2. Got O.J.

(c−八〇−75)はアスノやラギン醒が75モル係で
1.99あった。
(c-80-75) was 1.99 at 75 moles for Asuno and Ragin Kai.

実施例2 酵素による分解 実施例1により製造したポリアミノ酸50m9をリン酸
緩衝液10m1(0,1M)に溶解した。酵素としてフ
ィシン2m9又はノやノやイン2In9(1mJのリン
酸緩伽液中システィン及びEDTAをそれぞれ0、04
 mmol含有。)を加え、370でゆっくり攪拌させ
経時的に粘度を求め分子量の低下を追跡した分子量が二
分の−になるまでの時間を測定し、その時間の逆数を分
解速度(V)と定義した。
Example 2 Enzymatic Decomposition 50m9 of the polyamino acid produced in Example 1 was dissolved in 10ml of phosphate buffer (0.1M). As enzymes, ficin 2m9 or Noyanoyain 2In9 (cysteine and EDTA in 1 mJ phosphoric acid solution were 0 and 04, respectively).
Contains mmol. ) was added and slowly stirred at 370°C to determine the viscosity over time and track the decrease in molecular weight.The time until the molecular weight decreased to -2 was measured, and the reciprocal of that time was defined as the decomposition rate (V).

表1と第1図にフィシンについて、表2と第2図にパパ
インによる実験結果を示した。
Table 1 and FIG. 1 show the experimental results for ficin, and Table 2 and FIG. 2 show the experimental results for papain.

この結果から明らかな如く、アスパラギン酸の含量が多
いポリアミノ酸は酵素による分解が遅くなる。
As is clear from this result, polyamino acids with a high content of aspartic acid are degraded slowly by enzymes.

(発明の効果) 以上から明らかな如く、本発明によりアスパラギン酸を
その構成アミノ酸の一部に使用することにより得られる
水溶性アミノ酸ポリマーの生体酵素による分解速度を任
意に制御できるので、特に医薬品産業において本発明は
極めて有用である。
(Effects of the Invention) As is clear from the above, the present invention allows the decomposition rate of a water-soluble amino acid polymer obtained by using aspartic acid as a part of its constituent amino acids to be arbitrarily controlled by living enzymes. The present invention is extremely useful in this regard.

【図面の簡単な説明】[Brief explanation of the drawing]

実施例2におけるフィシンによる分解実験の結果を第1
図に/′P/4’インによる分解実験の結果を第2図に
、それぞれ示した。
The results of the decomposition experiment using ficin in Example 2 were
The results of a decomposition experiment using /'P/4'in are shown in Figure 2.

Claims (5)

【特許請求の範囲】[Claims] (1)構成アミノ酸としてアスパラギン酸を含むアミノ
酸ポリマーを含有することを特徴とする生体分解徐放性
材料。
(1) A biodegradable sustained-release material characterized by containing an amino acid polymer containing aspartic acid as a constituent amino acid.
(2)アミノ酸ポリマーが水溶性である請求項1記載の
材料。
(2) The material according to claim 1, wherein the amino acid polymer is water-soluble.
(3)アミノ酸ポリマーの分子量が1,000〜1,0
00,000である請求項1記載の材料。
(3) The molecular weight of the amino acid polymer is 1,000 to 1,0
2. The material of claim 1, wherein the material is 0.00,000.
(4)構成アミノ酸がL−体である請求項1記載の材料
(4) The material according to claim 1, wherein the constituent amino acids are L-form.
(5)アミノ酸ポリマーが構成アミノ酸としてアスパラ
ギン酸とグルタミン酸を含有する請求項1記載の材料。
(5) The material according to claim 1, wherein the amino acid polymer contains aspartic acid and glutamic acid as constituent amino acids.
JP11019988A 1988-05-06 1988-05-06 Biodegradable sustained release material Pending JPH01283228A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP11019988A JPH01283228A (en) 1988-05-06 1988-05-06 Biodegradable sustained release material

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11019988A JPH01283228A (en) 1988-05-06 1988-05-06 Biodegradable sustained release material

Publications (1)

Publication Number Publication Date
JPH01283228A true JPH01283228A (en) 1989-11-14

Family

ID=14529561

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11019988A Pending JPH01283228A (en) 1988-05-06 1988-05-06 Biodegradable sustained release material

Country Status (1)

Country Link
JP (1) JPH01283228A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH073010A (en) * 1993-04-23 1995-01-06 Rhone Poulenc Chim Polyanhydroaspartic acid and its biodegradable hydrolyzate

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH073010A (en) * 1993-04-23 1995-01-06 Rhone Poulenc Chim Polyanhydroaspartic acid and its biodegradable hydrolyzate

Similar Documents

Publication Publication Date Title
Liu et al. Preparation and applications of peptide-based injectable hydrogels
Mallakpour et al. Progress in synthetic polymers based on natural amino acids
Zhou et al. Advances and biomedical applications of polypeptide hydrogels derived from α‐amino acid N‐carboxyanhydride (NCA) polymerizations
Tabata et al. Protein release from gelatin matrices
Sanborn et al. In situ crosslinking of a biomimetic peptide-PEG hydrogel via thermally triggered activation of factor XIII
Lu et al. Mussel-inspired thermoresponsive polypeptide–pluronic copolymers for versatile surgical adhesives and hemostasis
US9149566B2 (en) Coatings and biomedical implants formed from keratin biomaterials
KR101895245B1 (en) Amphiphilic linear peptide/peptoid and hydrogel comprising the same
US6033654A (en) Bonding together tissue with adhesive containing polyfunctional crosslinking agent and protein polymer
US11191842B2 (en) Injectable thermoresponsive polyelectrolytes
Khan et al. Biodegradable polymers derived from amino acids
ATE451116T1 (en) PHARMACEUTICAL FORMULATIONS FOR SUSTAINED RELEASE OF ONE OR MORE ACTIVE INGREDIENTS AND THEIR THERAPEUTIC APPLICATIONS
EP0580702A1 (en) Polyamino acid superabsorbents
CA2556426A1 (en) Wound dressings comprising a protein polymer and a polyfunctional spacer
CY1110106T1 (en) PHARMACEUTICAL FORMS FOR THE LONG-TERM FREE INTERFERENCE AND THERAPEUTIC APPLICATIONS
IL175543A (en) Liquid pharmaceutical formulations for prolonged release of interleukin(s), process for their preparation and derived product comprising submicron particles containing such formulations
WO2011035319A2 (en) Self-assembling poly(diol citrates)-protein hydrogels
CN110396124B (en) Self-assembling polypeptides and their use as hemostatic agents
EP1173517A1 (en) In situ forming hydrogels
WO2020198644A1 (en) Mixtures of synthetic copolypeptide hydrogels
Kaufmann et al. Development and cytotoxicity evaluation of a cylindrical pH-responsive chitosan-genipin hydrogel for the oral delivery of diclofenac sodium
Liu et al. Biomimetic adhesives and coatings based on mussel adhesive proteins
JPH01283228A (en) Biodegradable sustained release material
US20170100484A1 (en) Drug delivery carrier for sustained release of medicinal proteins and method for production thereof
Pattammattel et al. Stimuli-responsive, protein hydrogels for potential applications in enzymology and drug delivery^\S §